The second study, conducted in a Korean cohort receiving Lactobacillus reuteri and Bifidobacterium adolescentis, reported significant improvements on the Beck Depression Inventory-II and reduced interleukin-6 levels. This evidence concerns the gene IL6 and depressive symptom measurement.